BAUPOST GROUP LLC/MA

Holdings History for THERAVANCE BIOPHARMA INC - NOTE 3.250%11/0

Investment type: Debt / NOTE 3.250%11/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Sep 2022		-0.38%	$0	0	-28,104,000	-100%		Q3 2022
30 Jun 2022	0.38%	-0.03%	$25,912,000	28,104,000	-1,896,000	-6.3%	92.2%	Q2 2022
31 Mar 2022	0.31%	0%	$28,562,000	30,000,000	0		95.21%	Q1 2022
31 Dec 2021	0.28%	0%	$28,783,000	30,000,000	0		95.94%	Q4 2021
30 Sep 2021	0.25%	0%	$27,640,000	30,000,000	0		92.13%	Q3 2021
30 Jun 2021	0.23%	0%	$28,559,000	30,000,000	0		95.2%	Q2 2021
31 Mar 2021	0.24%	0%	$30,580,000	30,000,000	0		101.93%	Q1 2021
31 Dec 2020	0.26%	0%	$28,396,000	30,000,000	0		94.65%	Q4 2020
30 Sep 2020	0.28%	0%	$26,281,000	30,000,000	0		87.6%	Q3 2020
30 Jun 2020	0.36%	0%	$29,184,000	30,000,000	0		97.28%	Q2 2020
31 Mar 2020	0.42%	0%	$28,688,000	30,000,000	0		95.63%	Q1 2020
31 Dec 2019	0.34%	0%	$31,118,000	30,000,000	0		103.73%	Q4 2019
30 Sep 2019	0.31%	0%	$27,656,000	30,000,000	0		92.19%	Q3 2019
30 Jun 2019	0.23%	0%	$25,725,000	30,000,000	0		85.75%	Q2 2019
31 Mar 2019	0.25%	0%	$29,213,000	30,000,000	0		97.38%	Q1 2019
31 Dec 2018	0.27%	0%	$30,863,000	30,000,000	0		102.88%	Q4 2018
30 Sep 2018	0.26%	0%	$34,575,000	30,000,000	0		115.25%	Q3 2018
30 Jun 2018	0.26%	0%	$29,963,000	30,000,000	0		99.88%	Q2 2018
31 Mar 2018	0.29%	0%	$30,206,000	30,000,000	0		100.69%	Q1 2018
31 Dec 2017	0.33%	0%	$33,038,000	30,000,000	0		110.13%	Q4 2017
30 Sep 2017	0.46%	0%	$37,125,000	30,000,000	0		123.75%	Q3 2017
30 Jun 2017	0.46%	0%	$40,388,000	30,000,000	0		134.63%	Q2 2017
31 Mar 2017	0.44%	0%	$37,763,000	30,000,000	0		125.88%	Q1 2017
31 Dec 2016	0.44%	+0.44%	$34,059,000	30,000,000	+30,000,000	NEW	113.53%	Q4 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.